Facebook icon Twitter icon Forward icon

New diabetic retinopathy drug a step closer

A new treatment for diabetic retinopathy has started being tested in people for the first time.

The trials of experimental drug KVD001 began this month, focussing on assessing the safety and tolerability of the drug in treating diabetic macular oedema, a particular type of retinopathy.

The trials are being conducted at the internationally acclaimed Beetham Eye Institute, with recruitment due to be gradually rolled out through five centres in the US.

Manufacturer KalVista, based in Hampshire, has been working with JDRF on the drug for a number of years.

Rachel Connor, Head of Research Communication at JDRF in the UK said: “So, we’re excited to see KVD001, a drug that we have helped Kalvista to develop, make it to the first phase of clinical testing. There is of course still a long way to go, but if this treatment works it will provide a new option for people who develop diabetic macular oedema.” To read more, click here.

Diabetes cycling team saddle up for tour

The first all-diabetes professional cycling team have been competing on British roads for the first time this month in the country’s leading race.

Team Novo Nordisk is taking part in The Tour of Britain between September 7 and 14 in a bid to help inspire, educate and empower the 3.2 million people affected by diabetes in the UK.

It is a global sports team with more than 100 cyclists, triathletes and runners who live with diabetes, spearheaded by the professional cycling team. This unique team of cyclists all have Type 1 diabetes, and manage their condition while training and competing in one of the toughest endurance sports. To read more, click here.

Charity hits out at ‘pre-diabetes’ scare

The “artificially created” medical condition pre-diabetes could be causing more harm than good, according to the InDependent Diabetes Trust (IDDT).

The recently conceived term ‘pre-diabetes’ refers to slightly increased glucose levels but not high enough for diabetes but leading medics say it is an “artificial category with virtually zero clinical relevance”.

The IDDT has been bombarded with calls from people concerned over being labelled as ‘pre-diabetic’, with healthcare professionals even prescribing blood sugar-lowering drugs for the “non condition”.

In a position statement on pre-diabetes released today, the charity said pre-diabetes was not a medical condition and using this term can do more harm than good. To read more, click here.

Sanofi release children's diabetes app

A new app to encourage children to learn more about how to live with diabetes has been launched.

Mission T1D by Sanofi Diabetes is aimed at children with Type 1 diabetes and their parents and carers.

The free game – available on Apple, android and PC devices – takes place in a school setting and features educational messages for primary school children. To read more, click here.